pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,574 catalysts · 3,126 8k filing · 2,046 grant · 1,007 approval · 1,000 device adverse event · 732 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 97 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-21×clear all
type
  • 8k filing3,126
  • grant2,046
  • approval1,007
  • device adverse event1,000
  • device 510k732
  • earnings583
device pma
539
  • device recall255
  • recall204
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 19, 2026

    17
    ›Jan 24, 2026approval200d agoCARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval200d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval200d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval200d agoNAPROXEN SODIUM — FDA approvalBayer HealthCare Pharmaceuticals Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 24, 2026approval200d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026approval200d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026approval200d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

    Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Jan 24, 2026device 510k200d agoVydence Medical Industria E Commercio Ltda — Vydence Family of Lasers (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 24, 2026device 510k200d agoGuangzhou Potent Medical Equipment Joint-Stock Co., Ltd. — Holmium Laser Therapeutic Apparatus (HZ-40) (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026approval199d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 25, 2026grant199d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Ovarian Steroid Mechanisms of Female Cannabis Use: Longitudinal and Experimen...Bedrocan BV

    DA grant. $54,538. PI: Anna Patterson

    full page →nih reporter ↗

    Week of Jan 26, 2026

    33
    ›Jan 26, 2026approval198d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval
    ← prev
    page 4 of 192
    next →
    198d ago
    BETAMETHASONE DIPROPIONATE — FDA approvalBETAMETHASONE DIPROPIONATE

    Sponsor: AUROBINDO PHARMA LTD. Form: CREAM. Route: TOPICAL

    full page →BETAMETHASONE DIPROPIONATE →fda approvals ↗
    ›Jan 26, 2026approval198d agoPALIPERIDONE — FDA approvalpaliperidone ER

    Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →paliperidone ER →fda approvals ↗
    ›Jan 26, 2026approval198d agoMETHYLPREDNISOLONE ACETATE — FDA approvalPFIZER INC

    Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 26, 2026approval198d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Jan 26, 2026approval198d agoFINASTERIDE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval198d agoCHLORPROMAZINE HYDROCHLORIDE — FDA approvalCHLORPROMAZINE HYDROCHLORIDE

    Sponsor: MSN. Form: INJECTABLE. Route: INJECTION

    full page →CHLORPROMAZINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 26, 2026approval198d agoTRANEXAMIC ACID — FDA approvalHyloris Pharmaceuticals SA

    Sponsor: I 3 PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2026approval198d agoDIFLUPREDNATE — FDA approvalDIFLUPREDNATE

    Sponsor: ALEMBIC. Form: EMULSION. Route: OPHTHALMIC

    full page →DIFLUPREDNATE →fda approvals ↗
    ›Jan 26, 2026approval198d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Jan 26, 2026approval198d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

    Sponsor: ACCORD HLTHCARE. Form: POWDER. Route: INTRAVENOUS

    full page →Daptomycin Novo →fda approvals ↗
    ›Jan 26, 2026approval198d agoBUDESONIDE — FDA approvalbudesonide DR

    Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →budesonide DR →fda approvals ↗
    ›Jan 26, 2026approval198d agoQUIOFIC (FOLIC ACID) — FDA approvalfolic acid

    Sponsor: SOLUBIOMIX. Form: SOLUTION. Route: ORAL

    full page →folic acid →fda approvals ↗
    ›Jan 26, 2026approval198d agoCUPRIC CHLORIDE — FDA approvalCUPRIC CHLORIDE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →CUPRIC CHLORIDE →fda approvals ↗
    ›Jan 26, 2026device 510k198d agoOutset Medical, Inc. — Tablo Hemodialysis System (PN-0008000, PN-0006000U) (510k cleared)Outset Medical, Inc.

    Product code: KDI. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 26, 2026device 510k198d agoEyas Medical Imaging, Inc. — Ascent3T Neonatal Magnetic Resonance Imaging System (510k cleared)

    Product code: LNH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 26, 2026device 510k198d agoGe Medical Systems Information Technologies, Inc. — MAC 7 Resting ECG Analysis System (510k cleared)

    Product code: DPS. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 26, 2026device pma198d agoDiaSorin, Inc. — LIAISON QuantiFERON TB Gold Plus II; LIAISON Control QuantiFERON TB Gold Plus II (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: NCD. Advisory committee: MI. Decision: APPR

    full page →fda device pma ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 M12 System Model Numbers: (1)722078, (2)722223, (3)722233; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 M20 System Model Numbers: (1)722079, (2)722224, (3)722234, (4)722282(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 B12 System Model Numbers:(1) 722067, (2) 722225, (3) 722235; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 5 M12 System Model Numbers: (1)722227, (2)722231; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 3 M15 System Model Numbers: (1) 722064, (2) 722222, (3) 722230, (4)722280(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 3 M12 System Model Numbers: (1) 722063, (2) 722221, (3) 722229; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 7 B20 System Model Numbers: (1)722068, (2)722226, (3)722236; Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026device recall198d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Azurion 5 M20 System Model Numbers: (1)722228, (2)722232, (3)722281(OUS only); Software Version Number - All versions: R1.X, R2.X, R3.X — Reason: Under certain conditions, the table may move unexpectedly when the Reset Geometry button is pressed - even when a table lock is active. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 26, 2026grant198d agoFLORIDA INTERNATIONAL UNIVERSITY — CRISPR/dCas9-Targeted Histone Demethylation Interplays with DNA Repair to Con...

    NS grant. $1,319,674. PI: Prem P Chapagain

    full page →nih reporter ↗
    ›Jan 26, 2026grant198d agoEMORY UNIVERSITY — Neuromodulation of somato-sympathetic postganglionic activity after SCIEmory University

    NS grant. $234,750. PI: SHAWN HOCHMAN

    full page →nih reporter ↗
    ›Jan 27, 2026approval197d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Jan 27, 2026approval197d agoNOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approvalPOSACONAZOLE

    Sponsor: MSD MERCK CO. Form: FOR SUSPENSION, DELAYED RELEASE. Route: ORAL

    full page →POSACONAZOLE →fda approvals ↗
    ›Jan 27, 2026approval197d agoTAPENTADOL HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: HUMANWELL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 27, 2026approval197d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →POSACONAZOLE →fda approvals ↗
    ›Jan 27, 2026approval197d agoFIDAXOMICIN — FDA approvalDificid

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →Dificid →fda approvals ↗
    $MRK130.88-0.03%
    $OM4.5200-1.09%
    $PFE26.63-1.57%
    $AMRX17.10-4.36%
    $AMRX17.10-4.36%
    $COLL25.98-4.49%